VRTX logo

VRTX Book Value

Annual Book Value:

$16.41B-$1.17B(-6.66%)
December 31, 2024

Summary

  • As of April 2, 2025, VRTX annual book value is $16.41 billion, with the most recent change of -$1.17 billion (-6.66%) on December 31, 2024.
  • During the last 3 years, VRTX annual book value has risen by +$6.31 billion (+62.47%).
  • VRTX annual book value is now -6.66% below its all-time high of $17.58 billion, reached on December 31, 2023.

Performance

VRTX Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRTXbalance sheetmetrics:

Quarterly Book Value:

$16.41B+$778.70M(+4.98%)
December 31, 2024

Summary

  • As of April 2, 2025, VRTX quarterly book value is $16.41 billion, with the most recent change of +$778.70 million (+4.98%) on December 31, 2024.
  • Over the past year, VRTX quarterly book value has stayed the same.
  • VRTX quarterly book value is now -11.52% below its all-time high of $18.55 billion, reached on March 31, 2024.

Performance

VRTX Quarterly Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRTXbalance sheetmetrics:

Book Value Formula

Book Value = Total Assets − Total Liabilities

VRTX Book Value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.7%0.0%
3 y3 years+62.5%+25.9%
5 y5 years+169.7%+25.9%

VRTX Book Value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.7%+62.5%-11.5%+50.5%
5 y5-year-6.7%+169.7%-11.5%+153.9%
alltimeall time-6.7%>+9999.0%-11.5%>+9999.0%

Vertex Pharmaceuticals Incorporated Book Value History

DateAnnualQuarterly
Dec 2024
$16.41B(-6.7%)
$16.41B(+5.0%)
Sep 2024
-
$15.63B(+5.8%)
Jun 2024
-
$14.77B(-20.3%)
Mar 2024
-
$18.55B(+5.5%)
Dec 2023
$17.58B(+26.4%)
$17.58B(+6.5%)
Sep 2023
-
$16.51B(+6.7%)
Jun 2023
-
$15.47B(+7.2%)
Mar 2023
-
$14.43B(+3.7%)
Dec 2022
$13.91B(+37.7%)
$13.91B(+6.8%)
Sep 2022
-
$13.03B(+9.2%)
Jun 2022
-
$11.93B(+9.4%)
Mar 2022
-
$10.91B(+8.0%)
Dec 2021
$10.10B(+16.3%)
$10.10B(+6.0%)
Sep 2021
-
$9.53B(+3.6%)
Jun 2021
-
$9.20B(+2.4%)
Mar 2021
-
$8.98B(+3.4%)
Dec 2020
$8.69B(+42.8%)
$8.69B(+6.8%)
Sep 2020
-
$8.13B(+8.2%)
Jun 2020
-
$7.52B(+16.4%)
Mar 2020
-
$6.46B(+6.2%)
Dec 2019
$6.09B(+37.2%)
$6.09B(+15.8%)
Sep 2019
-
$5.25B(+3.6%)
Jun 2019
-
$5.07B(+7.3%)
Mar 2019
-
$4.72B(+6.5%)
Dec 2018
$4.44B(+118.6%)
$4.44B(+52.6%)
Sep 2018
-
$2.91B(+8.2%)
Jun 2018
-
$2.69B(+11.9%)
Mar 2018
-
$2.40B(+18.4%)
Dec 2017
$2.03B(+75.4%)
$2.03B(+13.3%)
Sep 2017
-
$1.79B(+7.2%)
Jun 2017
-
$1.67B(+11.4%)
Mar 2017
-
$1.50B(+29.7%)
Dec 2016
$1.16B(+23.0%)
$1.16B(+13.2%)
Sep 2016
-
$1.02B(+4.1%)
Jun 2016
-
$981.35M(+2.5%)
Mar 2016
-
$957.08M(+1.8%)
Dec 2015
$939.97M(-12.6%)
$939.97M(+1.9%)
Sep 2015
-
$922.15M(+3.0%)
Jun 2015
-
$894.96M(-8.3%)
Mar 2015
-
$976.46M(-9.2%)
Dec 2014
$1.08B(-20.7%)
$1.08B(-7.0%)
Sep 2014
-
$1.16B(-1.4%)
Jun 2014
-
$1.17B(-4.8%)
Mar 2014
-
$1.23B(-9.3%)
Dec 2013
$1.36B(+35.8%)
$1.36B(+7.2%)
Sep 2013
-
$1.26B(-4.4%)
Jun 2013
-
$1.32B(+77.2%)
Mar 2013
-
$746.12M(-25.3%)
Dec 2012
$999.18M(+27.0%)
$999.18M(-2.8%)
Sep 2012
-
$1.03B(-1.0%)
Jun 2012
-
$1.04B(+11.5%)
Mar 2012
-
$930.50M(+18.3%)
Dec 2011
$786.84M(+56.1%)
$786.84M(+35.7%)
Sep 2011
-
$579.76M(+88.5%)
Jun 2011
-
$307.55M(-21.5%)
Mar 2011
-
$391.67M(-22.3%)
Dec 2010
$503.97M(-54.0%)
$503.97M(-22.5%)
Sep 2010
-
$650.10M(-21.4%)
Jun 2010
-
$827.13M(-16.5%)
Mar 2010
-
$990.61M(-9.6%)
Dec 2009
$1.10B(+359.0%)
$1.10B(+80.1%)
Sep 2009
-
$608.74M(-16.5%)
Jun 2009
-
$729.06M(+3.1%)
Mar 2009
-
$706.85M(+195.9%)
Dec 2008
$238.87M(-12.0%)
$238.87M(-31.7%)
Sep 2008
-
$349.89M(+45.8%)
Jun 2008
-
$239.93M(-21.1%)
Mar 2008
-
$304.25M(+12.1%)
DateAnnualQuarterly
Dec 2007
$271.30M(-46.4%)
$271.30M(-18.3%)
Sep 2007
-
$332.04M(-19.9%)
Jun 2007
-
$414.58M(-17.3%)
Mar 2007
-
$501.30M(-0.9%)
Dec 2006
$505.94M(+111.5%)
$505.94M(-0.4%)
Sep 2006
-
$507.77M(+190.2%)
Jun 2006
-
$175.00M(-24.9%)
Mar 2006
-
$232.91M(-2.6%)
Dec 2005
$239.18M(+574.9%)
$239.18M(+79.4%)
Sep 2005
-
$133.31M(+8.4%)
Jun 2005
-
$122.96M(-1548.1%)
Mar 2005
-
-$8.49M(-124.0%)
Dec 2004
$35.44M(-81.6%)
$35.44M(-52.3%)
Sep 2004
-
$74.32M(-32.6%)
Jun 2004
-
$110.29M(-29.8%)
Mar 2004
-
$157.10M(-18.5%)
Dec 2003
$192.84M(-49.1%)
$192.84M(-16.6%)
Sep 2003
-
$231.28M(-26.2%)
Jun 2003
-
$313.52M(-21.7%)
Mar 2003
-
$400.27M(+5.7%)
Dec 2002
$378.58M(-20.4%)
$378.58M(-7.3%)
Sep 2002
-
$408.21M(-6.5%)
Jun 2002
-
$436.68M(-3.0%)
Mar 2002
-
$450.11M(-5.3%)
Dec 2001
$475.35M(-7.5%)
$475.35M(-0.2%)
Sep 2001
-
$476.29M(+24.9%)
Jun 2001
-
$381.35M(-2.4%)
Mar 2001
-
$390.71M(-24.0%)
Dec 2000
$514.01M(+145.7%)
$514.01M(+126.8%)
Sep 2000
-
$226.60M(+0.7%)
Jun 2000
-
$225.11M(+11.6%)
Mar 2000
-
$201.74M(-3.6%)
Dec 1999
$209.23M(-15.0%)
$209.23M(+1.3%)
Sep 1999
-
$206.50M(-5.5%)
Jun 1999
-
$218.60M(-4.7%)
Mar 1999
-
$229.50M(-6.8%)
Dec 1998
$246.20M(-10.8%)
$246.20M(-5.0%)
Sep 1998
-
$259.10M(-0.1%)
Jun 1998
-
$259.30M(-3.4%)
Mar 1998
-
$268.40M(-2.8%)
Dec 1997
$276.00M(+111.0%)
$276.00M(-2.0%)
Sep 1997
-
$281.50M(-1.6%)
Jun 1997
-
$286.00M(+3.9%)
Mar 1997
-
$275.20M(+110.4%)
Dec 1996
$130.80M(+53.3%)
$130.80M(-2.2%)
Sep 1996
-
$133.70M(+116.7%)
Jun 1996
-
$61.70M(-21.3%)
Mar 1996
-
$78.40M(-8.1%)
Dec 1995
$85.30M(-19.1%)
$85.30M(-0.4%)
Sep 1995
-
$85.60M(-7.4%)
Jun 1995
-
$92.40M(-8.4%)
Mar 1995
-
$100.90M(-4.4%)
Dec 1994
$105.50M(+113.1%)
$105.50M(+11.4%)
Sep 1994
-
$94.70M(-4.4%)
Jun 1994
-
$99.10M(-5.2%)
Mar 1994
-
$104.50M(+111.1%)
Dec 1993
$49.50M(+12.8%)
$49.50M(+21.9%)
Sep 1993
-
$40.60M(-6.0%)
Jun 1993
-
$43.20M(+6.4%)
Mar 1993
-
$40.60M(-7.5%)
Dec 1992
$43.90M(-15.9%)
$43.90M(-5.6%)
Sep 1992
-
$46.50M(-4.3%)
Jun 1992
-
$48.60M(-4.0%)
Mar 1992
-
$50.60M(-3.1%)
Dec 1991
$52.20M(+903.8%)
$52.20M(+87.8%)
Sep 1991
-
$27.80M(+969.2%)
Jun 1991
-
$2.60M(-50.0%)
Dec 1990
$5.20M
$5.20M

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual book value?
  • What is the all time high annual book value for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual book value year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly book value?
  • What is the all time high quarterly book value for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly book value year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual book value?

The current annual book value of VRTX is $16.41B

What is the all time high annual book value for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual book value is $17.58B

What is Vertex Pharmaceuticals Incorporated annual book value year-on-year change?

Over the past year, VRTX annual book value has changed by -$1.17B (-6.66%)

What is Vertex Pharmaceuticals Incorporated quarterly book value?

The current quarterly book value of VRTX is $16.41B

What is the all time high quarterly book value for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly book value is $18.55B

What is Vertex Pharmaceuticals Incorporated quarterly book value year-on-year change?

Over the past year, VRTX quarterly book value has changed by $0.00 (0.00%)
On this page